PPARγ-dependent and -independent effects of Rosiglitazone on lipotoxic human pancreatic islets
Authors:
- Ericka MoermanEMEricka Moerman
- Bruno LefebvreBLBruno Lefebvre
- Frédérique DefranceFDFrédérique Defrance
- Valéry GmyrVGValéry Gmyr
- Bruno LukowiakBLBruno Lukowiak
- Julie Kerr ConteJCJulie Kerr Conte
- François PattouFPFrançois Pattou
- 1 February 2008
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 366 (4) , 1096-1101
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- β-Cell Failure in Diabetes and Preservation by Clinical TreatmentEndocrine Reviews, 2007
- Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARγ2 in the modulation of insulin secretionAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Effects of free fatty acids on insulin secretion in obesityObesity Reviews, 2002
- Direct Thiazolidinedione Action on Isolated Rat Skeletal Muscle Fuel Handling Is Independent of Peroxisome Proliferator–Activated Receptor-γ−Mediated Changes in Gene ExpressionDiabetes, 2001
- PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammationNature Medicine, 2001
- Expression of peroxisome proliferator-activated receptor γ (PPARγ) in normal human pancreatic islet cellsDiabetologia, 2000
- Palmitate and oleate induce the immediate-early response genes c-fos and nur-77 in the pancreatic beta-cell line INS-1.Diabetes, 1999
- Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat.Endocrinology, 1996
- Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissuesFree Radical Biology and Medicine, 1996
- An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)Journal of Biological Chemistry, 1995